PetMed Express Inc.

NASDAQ: PETS · Real-Time Price · USD
3.06
-0.04 (-1.29%)
At close: Aug 15, 2025, 12:23 PM

PetMed Express Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Revenue
52.98M 59.57M 67.95M 66.5M 65.32M 71M 78.24M 62.41M 58.87M 65.39M 70.19M 66M 60.72M 67.39M 79.31M 71.68M 65.9M 75.44M 96.2M
Cost of Revenue
38.08M 42.26M 51.7M 50.22M 48.4M 50.94M 55.72M 45.02M 43.63M 46.94M 50.24M 46.6M 42.99M 48.21M 57.53M 51.16M 46.27M 52.42M 69.42M
Gross Profit
14.91M 17.31M 16.25M 16.28M 16.91M 20.06M 22.53M 17.38M 15.24M 18.45M 19.94M 19.4M 17.73M 19.17M 21.78M 20.52M 19.62M 23.02M 26.79M
Operating Income
-450K 554K 4.39M -3.83M -3.07M -441K -2.13M -7.11M -769K 2.96M 3.49M 7.06M 5.15M 8.09M 5.42M 8.39M 9.29M 10.47M 9.44M
Interest Income
28K 185K 95K 30K 136K 570K 194K 857K 299K 388K 117K 92K 84K 74K 85K 85K 73K 66K 90K
Pretax Income
-242K 925K 4.71M -3.48M -2.65M 383K -1M -6.03M 198K 3.61M 3.81M 7.43M 5.52M 8.33M 5.79M 8.85M 9.71M 10.88M 9.78M
Net Income
-707K 2.33M 3.75M -5.02M -2.03M -70K -887K -5.1M -19K 2.58M 2.77M 6.07M 4.26M 6.35M 4.43M 6.81M 7.61M 8.41M 7.77M
Selling & General & Admin
13.77M 15.1M 11.86M 20.22M 19.19M 17.47M 22.98M 23.5M 15.07M 14.63M 15.7M 11.65M 11.87M 10.39M 15.71M 11.5M 9.71M 11.94M 16.79M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
1.59M 1.66M n/a n/a n/a 1.71M 506K 994K 941K 858K 753K 687K 287K 170K 284K 377K 345K 338K 255K
Operating Expenses
15.36M 16.76M 11.86M 20.22M 19.19M 19.19M 24.65M 24.49M 16.01M 15.49M 16.45M 12.34M 12.58M 11.09M 16.36M 12.13M 10.33M 12.55M 17.35M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 117K n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
2.99M 4.61M 6.99M 5.97M 5.76M 5.51M 7.26M 4.55M 4.64M 3.88M 6.35M 3.36M 4.33M 3.44M 7.67M 4.26M 3.22M 5.13M 9.03M
Cost & Expenses
53.43M 59.02M 63.57M 70.44M 68.39M 71.44M 80.37M 69.52M 59.64M 62.43M 66.7M 58.95M 55.57M 59.3M 73.89M 63.29M 56.6M 64.97M 86.77M
Income Tax Expense
465K -1.4M 958K 1.54M -618K 453K -115K -927K 217K 1.03M 1.03M 1.37M 1.26M 1.98M 1.36M 2.04M 2.1M 2.46M 2.01M
Shares Outstanding (Basic)
20.63M 20.6M 20.51M 20.44M 20.43M 20.38M 20.33M 20.33M 20.3M 20.26M 20.21M 20.21M 20.21M 20.18M 20.11M 20.1M 20.09M 20.06M 19.98M
Shares Outstanding (Diluted)
20.63M 20.94M 20.94M 20.44M 20.43M 20.38M 20.33M 20.34M 20.3M 20.34M 20.29M 20.34M 20.33M 20.57M 20.2M 20.18M 20.1M 20.15M 20.04M
EPS (Basic)
-0.03 0.11 0.18 -0.25 -0.1 -0.00 -0.04 -0.25 -0.00 0.13 0.14 0.30 0.21 0.31 0.22 0.34 0.38 0.42 0.39
EPS (Diluted)
-0.03 0.11 0.18 -0.25 -0.1 -0.00 -0.04 -0.25 -0.00 0.13 0.14 0.30 0.21 0.31 0.22 0.34 0.38 0.42 0.39
EBITDA
1.14M 2.21M 6.11M -1.94M -1.3M 2.99M -450K -6.12M 172K 3.82M 4.24M 7.74M 5.86M 8.78M 6.07M 9.02M 9.91M 11.08M 10M
EBIT
-450K 554K 4.39M -3.83M -3.07M 1.28M -2.13M -7.11M -769K 2.96M 3.31M 7.43M 5.52M 8.33M 5.79M 8.85M 9.71M 10.88M 9.78M
Depreciation & Amortization
1.59M 1.66M 1.72M 1.9M 1.77M 1.71M 1.68M 994K 941K 858K 753K 687K 710K 694K 647K 636K 622K 607K 562K